Lantheus Holdings Inc. is weighing a sale after getting a takeover offer from Curium that values the radiopharma company at about $7 billion, according to people familiar with the matter.
Lantheus Holdings Inc. is weighing a sale after getting a takeover offer from Curium that values the radiopharma company at about $7 billion, according to people familiar with the matter.